US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

CRO Concept

2,482.49

+94.633.96%

Number of Gainers:2

Number of Losers:- -

Number of Flat:- -

PE:- -

High:2,498.43

Open:2,383.90

Low:2,374.81

Close:2,387.86

Volume:2.46M

Turnover:736.00M

Market Cap:60.86B

Float Cap:56.98B

Loading ...

Gartner Inc. Stock Underperforms Friday When Compared to Competitors

Cryoport Q3 Revenue Beats Estimates on Cell and Gene Therapy Growth, Lifts Fy2026 Guidance

Solventum Q3 Sales Fall Slightly Less than Expected; Raises FY Adj EPS Outlook

Charles River Labs is Maintained at Outperform by Evercore ISI Group

McGraw Hill Q2 Revenue Falls 5.5% as K-12 Declines

Charles River price target raised to $375 from $330 at Barclays

Charles River Laboratories International, Inc. : Jefferies Raises Target Price to $385 from $340

THOMSON REUTERS

Labcorp Holdings Inc. Stock Outperforms Competitors on Strong Trading Day

Pacific Biosciences Q3 Revenue Slightly Beats Expectations on SPRQ-Nx Adoption

Centene Corp. Stock Rises 12.6%, Outperforms Peers

Caris Life Sciences' Q3 Revenue Rises on Molecular Profiling Strength

IQVIA-Linked Kidney Transplant Study Targets Disease Recurrence

Charles River Laboratories International, Inc. Reports Results for the Quarter Ended September 30 - Earnings Summary

Charles River Exec Says it Expects Q4 Organic Growth to Stay at Mid-Single Digits in Dsa and High-Single Digits in Manufacturing

THOMSON REUTERS

Charles River Exec Says Co Does not Expect Pricing Benefit Until at Least H2 2027

THOMSON REUTERS

Charles River Exec Says Overtime Goal is to Cover Annual Cost Inflation Through Price Increases - Conf Call

THOMSON REUTERS

Charles River Laboratories Shares up 2.5% Premarket After Q3 Results Beat

THOMSON REUTERS

Charles River Q3 Adjusted EPS USD 3.09 Vs. IBES Estimate USD 2.97

Charles River Laboratories Q3 Revenue Beats Estimates, Lifts 2026 Outlook

Charles River Laboratories Q3 EPS Rises to $6.86

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www-web.itiger.com/stock/BK4530/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK4530","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4530\",,,,,undefined,":{"symbol":"BK4530","market":"US","secType":"PLATE","nameCN":"CRO Concept","latestPrice":2482.4917,"timestamp":1793998799999,"preClose":2387.862,"halted":0,"volume":2462831,"delay":0,"changeRate":0.039629,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Market Closed","change":94.629639,"latestTime":"11-06 16:00:00 EST","open":2383.9001,"high":2498.4275,"low":2374.808,"amount":735997789.646902,"amplitude":0.05177,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1794214800000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"pbRate":6.346145,"peRate":50.312972,"turnoverRate":0.012426,"increases":2,"decrements":0,"flats":0,"marketCap":60856040448,"floatMarketCap":56975861760},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4530\",,,,,undefined,":{"symbol":"BK4530","high":2498.4275,"amplitude":0.05177,"preClose":2387.862,"low":2374.808,"pbRate":"6.346145","latestPrice":2482.4917,"volume":2462831,"delay":0,"open":2383.9001,"prevYearClose":1899.2574,"prevWeekClose":2496.5842,"prevMonthClose":2496.5842,"prevQuarterClose":2381.0566,"fiveDayClose":2496.5842,"twentyDayClose":2332.951,"sixtyDayClose":2171.0833,"secType":"PLATE","market":"US","turnoverRate":0.012426,"peRate":50.312972,"marketCap":60856040448,"floatMarketCap":56975861760,"timestamp":1793998799999,"nameCN":"CRO Concept"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK4530\",,,,undefined,":{"bkCode":"BK4530","up":2,"down":0,"flat":0},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK4530\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2681978188","title":"Gartner Inc. Stock Underperforms Friday When Compared to Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2681978188","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2681978188?lang=en_us&edition=fundamental","pubTime":"2026-11-07 06:14","pubTimestamp":1794003240,"startTime":"0","endTime":"0","summary":"DJ Gartner Inc. Stock Underperforms Friday When Compared To CompetitorsThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Gartner Inc.  slipped 4.02% to $190.10 Friday, on what proved to be an all-around mixed trading session for the stock market, with the S&P 500 Index  rising 0.31% to 7,376.86 and the Dow Jones Industrial Average  falling 0.46% to 51,285.73.This was the stock's second consecutive day of losses.Gartner Inc. closed 26.00% below its 52-week high of $256.90, which the company reached on December 17th.The stock underperformed when compared to some of its competitors Friday, as Trade Desk Inc. Cl A  rose 0.94% to $12.93, IQVIA Holdings Inc.  rose 2.62% to $271.83, and Omnicom Group Inc.  fell 0.83% to $86.37.Trading volume  eclipsed its 50-day average volume of 1.1 M.Data source: Dow Jones Market Data, FactSet. Data compiled November 6, 2026.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1989764664.SGD","LU0154245756.USD","OMC","LU0477156953.USD","LU2237957811.SGD","LU1261432733.SGD","LU0130102774.USD","LU0130103400.USD","LU0648001328.SGD","BK4134","LU0154245673.USD","LU1548497426.USD","LU0477156797.USD","LU2357305700.SGD","LU0772969993.USD","LU0107464264.USD","LU1201861249.SGD","LU2362541513.USD","TTD","BK4528","LU0731783394.SGD","IQV","BK4121","LU1814569148.SGD","BK4548","IT","LU0198837287.USD","LU0348723411.USD","LU1720051017.SGD","BK4585","TTDU","LU0980610538.SGD","LU2517655291.USD","BK4613","LU0528227936.USD","LU1509826696.USD","LU0130518102.USD","LU2517655374.HKD","LU2362541273.HKD","HEAL","LU2237957902.USD","LU2517655028.SGD","LU1791710400.SGD","EKG","LU0882574055.USD","LU1599440770.SGD","BK4530","LU1201861165.SGD","RSPC","LU0321505439.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2681888177","title":"Cryoport Q3 Revenue Beats Estimates on Cell and Gene Therapy Growth, Lifts Fy2026 Guidance","url":"https://stock-news.laohu8.com/highlight/detail?id=2681888177","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2681888177?lang=en_us&edition=fundamental","pubTime":"2026-11-06 05:52","pubTimestamp":1793915552,"startTime":"0","endTime":"0","summary":"Cryoport Q3 revenue beats estimates on cell and gene therapy growth, lifts FY2026 guidanceOverviewUS life sciences supply chain firm's Q3 revenue rose 14% yr/yr, beating analyst expectationsQ3 adjuste","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261105:nL2N46M1IO:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4530","CYRX","IE00BFMHRM44.USD","LU0757428866.USD","LU0029874061.USD","BK4588","BK4602","CRL","LU1815336091.USD","LU0390134368.USD","BK4585","BK4121","LU0128526141.USD","FBT","BK4082","BRKR","TINY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2681000085","title":"Solventum Q3 Sales Fall Slightly Less than Expected; Raises FY Adj EPS Outlook","url":"https://stock-news.laohu8.com/highlight/detail?id=2681000085","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2681000085?lang=en_us&edition=fundamental","pubTime":"2026-11-06 05:26","pubTimestamp":1793913960,"startTime":"0","endTime":"0","summary":"Solventum Q3 sales fall slightly less than expected; raises FY adj EPS outlookOverviewUS healthcare products provider's Q3 sales fell 7% yr/yr but slightly beat analyst expectationsAdjusted EPS for Q3","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261105:nL2N46M1K7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2125909247.SGD","LU1923622614.USD","BK4585","LU2125909593.SGD","BK4588","LU0757428866.USD","LU0128526141.USD","QGEN","LU0390134368.USD","SOLV","LU1815336091.USD","CRL","BK4530","BK4198","BK4121","IE00BFMHRM44.USD","LU2433249047.HKD","LU0029874061.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2681071544","title":"Charles River Labs is Maintained at Outperform by Evercore ISI Group","url":"https://stock-news.laohu8.com/highlight/detail?id=2681071544","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2681071544?lang=en_us&edition=fundamental","pubTime":"2026-11-05 22:20","pubTimestamp":1793888400,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/CRL/analyst-ratings","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BFMHRM44.USD","LU1815336091.USD","BK4121","CRL","LU0029874061.USD","LU0128526141.USD","LU0757428866.USD","BK4530","BK4585","LU0390134368.USD","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2681417027","title":"McGraw Hill Q2 Revenue Falls 5.5% as K-12 Declines","url":"https://stock-news.laohu8.com/highlight/detail?id=2681417027","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2681417027?lang=en_us&edition=fundamental","pubTime":"2026-11-05 20:28","pubTimestamp":1793881715,"startTime":"0","endTime":"0","summary":"McGraw Hill Q2 revenue falls 5.5% as K-12 declinesOverviewUS education solutions provider's fiscal Q2 revenue fell 5.5% yr/yr, but topped company expectationsAdjusted EBITDA margin fell to 39.6% from ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261105:nL2N46M0PK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","BK4530","BK4204","LU0757428866.USD","STRA","LU0128526141.USD","CRL","MH","LU0390134368.USD","LU0029874061.USD","BK4121","IE00BFMHRM44.USD","LU1815336091.USD","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2681023990","title":"Charles River price target raised to $375 from $330 at Barclays","url":"https://stock-news.laohu8.com/highlight/detail?id=2681023990","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2681023990?lang=en_us&edition=fundamental","pubTime":"2026-11-05 18:35","pubTimestamp":1793874918,"startTime":"0","endTime":"0","summary":"Barclays raised the firm’s price target on Charles River (CRL) to $375 from $330 and keeps an Overweight rating on the shares post the Q3 report. T...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/charles-river-price-target-raised-to-375-from-330-at-barclays-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/charles-river-price-target-raised-to-375-from-330-at-barclays-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0390134368.USD","BK4588","IE00BFMHRM44.USD","LU0128526141.USD","LU0029874061.USD","CRL","LU1815336091.USD","BK4530","BK4121","BK4585","LU0757428866.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2681014683","title":"Charles River Laboratories International, Inc. : Jefferies Raises Target Price to $385 from $340","url":"https://stock-news.laohu8.com/highlight/detail?id=2681014683","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2681014683?lang=en_us&edition=fundamental","pubTime":"2026-11-05 13:33","pubTimestamp":1793856799,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261105:nFWN46M0FK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CRL","BK4530","BK4121","LU0029874061.USD","LU0390134368.USD","BK4588","BK4585","LU0757428866.USD","LU1815336091.USD","IE00BFMHRM44.USD","LU0128526141.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2681095239","title":"Labcorp Holdings Inc. Stock Outperforms Competitors on Strong Trading Day","url":"https://stock-news.laohu8.com/highlight/detail?id=2681095239","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2681095239?lang=en_us&edition=fundamental","pubTime":"2026-11-05 05:57","pubTimestamp":1793829420,"startTime":"0","endTime":"0","summary":"DJ Labcorp Holdings Inc. Stock Outperforms Competitors On Strong Trading DayThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Labcorp Holdings Inc.  rose 3.92% to $367.79 Wednesday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index  rising 1.58% to 7,688.62 and the Dow Jones Industrial Average  rising 3.03% to 53,356.12.The stock's rise snapped a three-day losing streak.Labcorp Holdings Inc. closed 0.87% short of its 52-week high of $371.00, which the company achieved on October 28th.The stock demonstrated a mixed performance when compared to some of its competitors Wednesday, as IQVIA Holdings Inc.  rose 0.46% to $263.79, Centene Corp.  rose 12.64% to $76.01, and Teladoc Health Inc.  rose 9.11% to $9.70.Trading volume  eclipsed its 50-day average volume of 767,920.Data source: Dow Jones Market Data, FactSet. Data compiled November 4, 2026.","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE0034235188.USD","LU2237438978.USD","EKG","LU0130103400.USD","LU2065169927.USD","LU0528227936.USD","LU2065171311.SGD","BK4550","IQV","LU0980610538.SGD","LU2237957811.SGD","LU2362540622.SGD","LU2362541513.USD","LU0648000940.SGD","BK4167","LU0006061336.USD","LU1989771016.USD","LU1861558580.USD","BK4588","BK4154","LU0477156953.USD","LU0130102774.USD","LU1699723380.USD","LU0882574055.USD","CNC","LU1201861165.SGD","LU1861559042.SGD","LU2065170008.USD","LU1261432733.SGD","TDOC","LU1059921491.USD","LU1791710582.SGD","BK4530","LU0130517989.USD","LU1989764748.USD","HEAL","LU1291159041.SGD","LU0742534661.SGD","BK4548","BK4585","CNCG","LU0477156797.USD","LU2065171402.SGD","LU2362541273.HKD","LU1791710400.SGD","LH","LU0048573561.USD","LU1201861249.SGD","LU1989764664.SGD","LU0130518102.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2681095466","title":"Pacific Biosciences Q3 Revenue Slightly Beats Expectations on SPRQ-Nx Adoption","url":"https://stock-news.laohu8.com/highlight/detail?id=2681095466","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2681095466?lang=en_us&edition=fundamental","pubTime":"2026-11-05 05:56","pubTimestamp":1793829410,"startTime":"0","endTime":"0","summary":"Pacific Biosciences Q3 revenue slightly beats expectations onSPRQ-Nx adoptionOverviewLife science sequencing tech firm's Q3 revenue was a slight beat versus analyst expectationsAdjusted loss per share","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261104:nL2N46L1EZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FBT","LU0757428866.USD","CRL","TINY","LU0390134368.USD","BK4530","LU0128526141.USD","BK4585","BK4121","IE00BFMHRM44.USD","PACB","LU1815336091.USD","BK4588","LU0029874061.USD","BRKR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2681100093","title":"Centene Corp. Stock Rises 12.6%, Outperforms Peers","url":"https://stock-news.laohu8.com/highlight/detail?id=2681100093","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2681100093?lang=en_us&edition=fundamental","pubTime":"2026-11-05 05:34","pubTimestamp":1793828040,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Centene Corp. climbed 12.6% to $76.01 on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index rising 1.6% to 7,688.62 and the Dow Jones Industrial Average rising 3.0% to 53,356.12.This was the stock's second consecutive day of gains.Centene Corp. hit a new 52-week high, surpassing its previous peak of $72.50, which the company achieved on October 22nd.The stock outperformed some of its peers, as HCA Healthcare Inc. rose 10.3% to $510.70, IQVIA Holdings Inc. rose 0.5% to $263.79, and Labcorp Holdings Inc. rose 3.92% to $367.79.Trading volume totaled 15.0 million, compared to the 50-day average of 4.7 million.Data source: Dow Jones Market Data, FactSet","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999014039.USD","BK4121","LU0130102774.USD","LU0130518102.USD","LU1291159041.SGD","LU2065170008.USD","CNCG","LU1699723380.USD","LH","LU2065171311.SGD","SG9999014005.SGD","EKG","LU0742534661.SGD","HEAL","IE0034235188.USD","LU0203345920.USD","LU0648001328.SGD","LU2362540622.SGD","LU0648000940.SGD","LU0310799852.SGD","LU1119994496.HKD","BK4530","LU0128525929.USD","LU1489326972.SGD","LU1150488135.SGD","LU2362541513.USD","LU0203347892.USD","SG9999014021.USD","LU2237957811.SGD","CNC","IE00B775SV38.USD","LU2244417387.USD","SG9999014013.SGD","LU0868494617.USD","IQV","LU2065169927.USD","LU1267930490.SGD","BK4196","LU0310800379.SGD","LU0859254822.USD","LU0068578508.USD","IHF","LU1989764748.USD","HCA","LU0433182093.SGD","LU0006061336.USD","LU1261432733.SGD","BK4550","LU1791710582.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2681406041","title":"Caris Life Sciences' Q3 Revenue Rises on Molecular Profiling Strength","url":"https://stock-news.laohu8.com/highlight/detail?id=2681406041","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2681406041?lang=en_us&edition=fundamental","pubTime":"2026-11-05 05:16","pubTimestamp":1793826978,"startTime":"0","endTime":"0","summary":"Caris Life Sciences' Q3 revenue rises on molecular profiling strengthOverviewUS molecular diagnostics firm's Q3 revenue rose 27% yr/yr, driven by molecular profiling growthNet income fell yr/yr as ope","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261104:nL2N46L1E6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","LU1815336091.USD","BK4139","CAI","BK4167","LU0390134368.USD","LU0128526141.USD","LU0757428866.USD","BK4588","BK4530","SOPH","STVN","CRL","LU0029874061.USD","BK4104","BK4585","IE00BFMHRM44.USD","BK4121"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2681065731","title":"IQVIA-Linked Kidney Transplant Study Targets Disease Recurrence","url":"https://stock-news.laohu8.com/highlight/detail?id=2681065731","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2681065731?lang=en_us&edition=fundamental","pubTime":"2026-11-05 00:32","pubTimestamp":1793809924,"startTime":"0","endTime":"0","summary":"IQVIA Holdings ($IQV) announced an update on their ongoing clinical study. Study Overview: IQVIA Holdings (IQV) is collaborating with Swedish Orpha...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/iqvia-linked-kidney-transplant-study-targets-disease-recurrence?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/iqvia-linked-kidney-transplant-study-targets-disease-recurrence?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1201861249.SGD","LU0130518102.USD","LU1201861165.SGD","LU1791710582.SGD","LU1261432733.SGD","LU0130517989.USD","BK4530","LU0882574055.USD","LU0648001328.SGD","LU0477156953.USD","BK4121","LU0980610538.SGD","BK4588","HEAL","LU2237957902.USD","BK4585","LU1791710400.SGD","LU0528227936.USD","LU1989764748.USD","LU0130102774.USD","LU0648000940.SGD","LU1989764664.SGD","IQV","LU0198837287.USD","EKG","LU0130103400.USD","LU2237957811.SGD","LU0477156797.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2680050698","title":"Charles River Laboratories International, Inc. Reports Results for the Quarter Ended September 30 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2680050698","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2680050698?lang=en_us&edition=fundamental","pubTime":"2026-11-04 22:31","pubTimestamp":1793802696,"startTime":"0","endTime":"0","summary":"Charles River Laboratories International, Inc. reports results for the quarter ended September 30 - Earnings SummaryCharles River Laboratories International, Inc.CRL.Nreported quarterly adjusted earni","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261104:nL5N46L24G:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0390134368.USD","LU0757428866.USD","BK4588","BK4121","BK4530","LU1815336091.USD","LU0029874061.USD","BK4585","IE00BFMHRM44.USD","CRL","LU0128526141.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2680605072","title":"Charles River Exec Says it Expects Q4 Organic Growth to Stay at Mid-Single Digits in Dsa and High-Single Digits in Manufacturing","url":"https://stock-news.laohu8.com/highlight/detail?id=2680605072","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2680605072?lang=en_us&edition=fundamental","pubTime":"2026-11-04 22:25","pubTimestamp":1793802358,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261104:nFWN46L2PR:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4121","IE00BFMHRM44.USD","LU0128526141.USD","BK4585","LU0757428866.USD","CRL","BK4588","BK4530","LU1815336091.USD","LU0390134368.USD","LU0029874061.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2680508350","title":"Charles River Exec Says Co Does not Expect Pricing Benefit Until at Least H2 2027","url":"https://stock-news.laohu8.com/highlight/detail?id=2680508350","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2680508350?lang=en_us&edition=fundamental","pubTime":"2026-11-04 22:25","pubTimestamp":1793802358,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261104:nFWN46L2PR:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CRL","LU0029874061.USD","LU1815336091.USD","BK4585","BK4588","BK4121","IE00BFMHRM44.USD","BK4530","LU0128526141.USD","LU0390134368.USD","LU0757428866.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2680057014","title":"Charles River Exec Says Overtime Goal is to Cover Annual Cost Inflation Through Price Increases - Conf Call","url":"https://stock-news.laohu8.com/highlight/detail?id=2680057014","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2680057014?lang=en_us&edition=fundamental","pubTime":"2026-11-04 22:25","pubTimestamp":1793802358,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261104:nFWN46L2PR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU1815336091.USD","LU0390134368.USD","LU0757428866.USD","BK4588","BK4530","CRL","LU0029874061.USD","LU0128526141.USD","BK4585","IE00BFMHRM44.USD","BK4121"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2680818056","title":"Charles River Laboratories Shares up 2.5% Premarket After Q3 Results Beat","url":"https://stock-news.laohu8.com/highlight/detail?id=2680818056","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2680818056?lang=en_us&edition=fundamental","pubTime":"2026-11-04 20:17","pubTimestamp":1793794660,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261104:nL2N46L0NP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CRL","BK4121","IE00BFMHRM44.USD","LU0029874061.USD","LU0390134368.USD","LU0757428866.USD","BK4588","LU1815336091.USD","LU0128526141.USD","BK4585","BK4530"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2680055760","title":"Charles River Q3 Adjusted EPS USD 3.09 Vs. IBES Estimate USD 2.97","url":"https://stock-news.laohu8.com/highlight/detail?id=2680055760","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2680055760?lang=en_us&edition=fundamental","pubTime":"2026-11-04 20:12","pubTimestamp":1793794326,"startTime":"0","endTime":"0","summary":"Nov 04 (Reuters) - Charles River Q3 EPS USD 6.86.:((Reuters Investor Briefs; email: reutersinvestor.briefs@thomsonreuters.com))Source Date/Time = 04-NOV-202612:01:01.12 GMT","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261104:nRSD78ngJ4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0128526141.USD","BK4588","IE00BFMHRM44.USD","LU0029874061.USD","LU0757428866.USD","BK4530","LU1815336091.USD","BK4121","CRL","LU0390134368.USD","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2680805542","title":"Charles River Laboratories Q3 Revenue Beats Estimates, Lifts 2026 Outlook","url":"https://stock-news.laohu8.com/highlight/detail?id=2680805542","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2680805542?lang=en_us&edition=fundamental","pubTime":"2026-11-04 20:10","pubTimestamp":1793794245,"startTime":"0","endTime":"0","summary":"Charles River Laboratories Q3 revenue beats estimates, lifts 2026 outlookOverviewU.S. drug development services firm's Q3 revenue fell 2.2% but beat analyst expectationsAdjusted EPS for Q3 rose 27% yr","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261104:nL2N46L0LS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MIRM","BK4530","IBBQ","LU2242652126.USD","TBXU","LU0757428866.USD","LU1057294990.SGD","BK4139","LU2112291526.USD","BBH","AMGN","LU0058720904.USD","LU1023059063.AUD","BK4566","IE00BFMHRM44.USD","LU0868494617.USD","IE00B2B36J28.USD","LU1815336091.USD","BIB","BK4581","LU0029874061.USD","IE00B4R5TH58.HKD","BK4599","IE0002141913.USD","BK4585","BK4533","LU0128526141.USD","LU0320765992.SGD","LU2089984988.USD","LU1983299246.USD","IE00BJJMRZ35.SGD","LU2242646821.SGD","CRL","LU1061106388.HKD","LU1571399168.USD","BK4534","PJP","IE00BFTCPJ56.SGD","LU0122379950.USD","LU0889565916.HKD","PBE","SG9999001440.SGD","LU0289739699.SGD","BK4588","IE00BJT1NW94.SGD","LU1236620834.HKD","LU0109394709.USD","IE0009355771.USD","IBB","LU2468319806.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2680505567","title":"Charles River Laboratories Q3 EPS Rises to $6.86","url":"https://stock-news.laohu8.com/highlight/detail?id=2680505567","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2680505567?lang=en_us&edition=fundamental","pubTime":"2026-11-04 20:06","pubTimestamp":1793794017,"startTime":"0","endTime":"0","summary":"Charles River Laboratories Q3 EPS rises to $6.86Charles River Laboratories’ third-quarter 2026 GAAP diluted earnings per share rose year-over-year to $6.86.Earnings included a $245.6 million benefit f","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261104:nNDL4j2qhf:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","BK4121","LU0390134368.USD","BK4530","LU0128526141.USD","LU0029874061.USD","LU0757428866.USD","CRL","LU1815336091.USD","IE00BFMHRM44.USD","BK4585"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":1,"totalSize":48,"code":"91000000","status":"200"}]}}